Avagimyan A, Kajaia A, Gabunia L, Ghambashidze K, Sulashvili N, Ratiani L, Heshmat-Ghahdarijani K, Sheibani M, Aznauryan A. Urotensin-II As a Promising Key-Point of Cardiovascular Disturbances Sequel.
Curr Probl Cardiol 2021;
47:101074. [PMID:
34848248 DOI:
10.1016/j.cpcardiol.2021.101074]
[Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2021] [Revised: 11/21/2021] [Accepted: 11/23/2021] [Indexed: 12/15/2022]
Abstract
Arterial hypertension is a highly urgent problem of modern medicine since the crisis of blood pressure control remains open, due to the increasing number of uncontrolled arterial hypertension. Today, one of the most critical problems of cardiology is the study of the mechanisms of development and progression of arterial hypertension. Therefore, our international and multidisciplinary working group presents a vision of a new therapeutic target - urotensin II in the pathogenesis of arterial hypertension. Thus, this article reflects the concept of the Armenian, Georgian and Iranian medical schools.
Collapse